113 related articles for article (PubMed ID: 33561562)
1. α
Wang Z; Zhao S; Gu W; Dong Y; Meng F; Yuan J; Zhong Z
Acta Biomater; 2021 Apr; 124():348-357. PubMed ID: 33561562
[TBL] [Abstract][Full Text] [Related]
2. Folate-mediated targeted PLK1 inhibition therapy for ovarian cancer: A comparative study of molecular inhibitors and siRNA therapeutics.
Wang Z; Zhao S; Shi J; Meng F; Yuan J; Zhong Z
Acta Biomater; 2022 Jan; 138():443-452. PubMed ID: 34757229
[TBL] [Abstract][Full Text] [Related]
3. HER-2-mediated nano-delivery of molecular targeted drug potently suppresses orthotopic epithelial ovarian cancer and metastasis.
Wang Z; Guo B; Yue S; Zhao S; Meng F; Zhong Z
Int J Pharm; 2022 Sep; 625():122126. PubMed ID: 35995316
[TBL] [Abstract][Full Text] [Related]
4. Transferrin-guided intelligent nanovesicles augment the targetability and potency of clinical PLK1 inhibitor to acute myeloid leukemia.
Xia Y; An J; Li J; Gu W; Zhang Y; Zhao S; Zhao C; Xu Y; Li B; Zhong Z; Meng F
Bioact Mater; 2023 Mar; 21():499-510. PubMed ID: 36185744
[TBL] [Abstract][Full Text] [Related]
5. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
[TBL] [Abstract][Full Text] [Related]
6. ATN-161 Peptide Functionalized Reversibly Cross-Linked Polymersomes Mediate Targeted Doxorubicin Delivery into Melanoma-Bearing C57BL/6 Mice.
Zhang N; Xia Y; Zou Y; Yang W; Zhang J; Zhong Z; Meng F
Mol Pharm; 2017 Aug; 14(8):2538-2547. PubMed ID: 28005375
[TBL] [Abstract][Full Text] [Related]
7. Brain delivery of Plk1 inhibitor via chimaeric polypeptide polymersomes for safe and superb treatment of orthotopic glioblastoma.
Fan Q; Liu Y; Cui G; Zhong Z; Deng C
J Control Release; 2021 Jan; 329():1139-1149. PubMed ID: 33131697
[TBL] [Abstract][Full Text] [Related]
8. HER2-Specific Reduction-Sensitive Immunopolymersomes with High Loading of Epirubicin for Targeted Treatment of Ovarian Tumor.
Ding L; Gu W; Zhang Y; Yue S; Sun H; Cornelissen JJLM; Zhong Z
Biomacromolecules; 2019 Oct; 20(10):3855-3863. PubMed ID: 31513391
[TBL] [Abstract][Full Text] [Related]
9. Smart Polymersomes Dually Functionalized with cRGD and Fusogenic GALA Peptides Enable Specific and High-Efficiency Cytosolic Delivery of Apoptotic Proteins.
Yao P; Zhang Y; Meng H; Sun H; Zhong Z
Biomacromolecules; 2019 Jan; 20(1):184-191. PubMed ID: 30289705
[TBL] [Abstract][Full Text] [Related]
10. Selective Cell Penetrating Peptide-Functionalized Polymersomes Mediate Efficient and Targeted Delivery of Methotrexate Disodium to Human Lung Cancer In Vivo.
Yang W; Xia Y; Fang Y; Meng F; Zhang J; Cheng R; Deng C; Zhong Z
Adv Healthc Mater; 2018 Apr; 7(7):e1701135. PubMed ID: 29280317
[TBL] [Abstract][Full Text] [Related]
11. Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo.
Wei Y; Gu X; Cheng L; Meng F; Storm G; Zhong Z
Acta Biomater; 2019 Jul; 92():196-204. PubMed ID: 31102765
[TBL] [Abstract][Full Text] [Related]
12. Lung cancer specific and reduction-responsive chimaeric polymersomes for highly efficient loading of pemetrexed and targeted suppression of lung tumor in vivo.
Yang W; Yang L; Xia Y; Cheng L; Zhang J; Meng F; Yuan J; Zhong Z
Acta Biomater; 2018 Apr; 70():177-185. PubMed ID: 29410335
[TBL] [Abstract][Full Text] [Related]
13. Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo.
Wei Y; Gu X; Sun Y; Meng F; Storm G; Zhong Z
J Control Release; 2020 Mar; 319():407-415. PubMed ID: 31923538
[TBL] [Abstract][Full Text] [Related]
14. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma.
Zhu D; Wu S; Hu C; Chen Z; Wang H; Fan F; Qin Y; Wang C; Sun H; Leng X; Kong D; Zhang L
Acta Biomater; 2017 Aug; 58():399-412. PubMed ID: 28627436
[TBL] [Abstract][Full Text] [Related]
15. Novel monoclonal antibody against integrin α3 shows therapeutic potential for ovarian cancer.
Ke FY; Chen WY; Lin MC; Hwang YC; Kuo KT; Wu HC
Cancer Sci; 2020 Oct; 111(10):3478-3492. PubMed ID: 32648337
[TBL] [Abstract][Full Text] [Related]
16. In vitro study of the Polo-like kinase 1 inhibitor volasertib in non-small-cell lung cancer reveals a role for the tumor suppressor p53.
Van den Bossche J; Deben C; De Pauw I; Lambrechts H; Hermans C; Deschoolmeester V; Jacobs J; Specenier P; Pauwels P; Vermorken JB; Peeters M; Lardon F; Wouters A
Mol Oncol; 2019 May; 13(5):1196-1213. PubMed ID: 30859681
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase 1 inhibition.
Chen JL; Chen JP; Huang YS; Tsai YC; Tsai MH; Jaw FS; Cheng JC; Kuo SH; Shieh MJ
Strahlenther Onkol; 2016 Apr; 192(4):260-8. PubMed ID: 26952039
[TBL] [Abstract][Full Text] [Related]
18. GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment.
Zou Y; Xia Y; Meng F; Zhang J; Zhong Z
Mol Pharm; 2018 Sep; 15(9):3664-3671. PubMed ID: 29570299
[TBL] [Abstract][Full Text] [Related]
19. Dually Active Targeting Nanomedicines Based on a Direct Conjugate of Two Purely Natural Ligands for Potent Chemotherapy of Ovarian Tumors.
Yan Y; Dong Y; Yue S; Qiu X; Sun H; Zhong Z
ACS Appl Mater Interfaces; 2019 Dec; 11(50):46548-46557. PubMed ID: 31763810
[TBL] [Abstract][Full Text] [Related]
20. Near-infrared optical imaging of ovarian cancer xenografts with novel alpha 3-integrin binding peptide "OA02".
Aina OH; Marik J; Gandour-Edwards R; Lam KS
Mol Imaging; 2005; 4(4):439-47. PubMed ID: 16285906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
